Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Genetic Engineering

No description
by

Sam Davis

on 28 April 2010

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Genetic Engineering

GENE PATENTING BRCA1 AND BRCA2 PATENTED BY MYRIAD Terms to Know Patent - How it works: genetic testing ETHICS? PRO CON INVESTMENT PROMOTION NOVEL GENES CASE STUDY 2 - some bacteria can metabolize
petroleum, allowing for more efficient oil spill
clean up STIFLES RESEARCH LACK OF INDEPENDENT VARIATION CREATES MONOPOLIES EXORBITANT FEES OWNERSHIP OF KNOWLEDGE SAM DAVIS, URI BULOW, DARYL GOLDMAN, MATTHEW SMELSER REFERENCES (2010). DNA: A patent problem. Daily Breeze. Retrieved from http://www.dailybreeze.com/opinions/ci_14909562.

(2010). Myriad Genetics falls as gene patents are voided. Business Week. Retrieved from http://www.businessweek.com/ap/financialnews/D9EP20LO0.htm.

Kesselheim, A.S. & Mello, M.M. (2010). Gene Patenting – Is the Pendulum Swinging Back. New England Journal of Medicine Online. Retrieved from http://content.nejm.org/cgi/content/full/NEJMp1004026.

Noonan, K.E. (2010). The Fantastical Economics of the Gene Patenting Debate. Patent Docs. Retrieved from http://www.patentdocs.org/2010/04/the-fantastical-economics-of-the-gene-patenting-debate.html.
patent - a document granting an inventor sole rights to an invention genetic testing - analysis of genetic code to show increased liklihood of disease monopoly - exclusive control of a commodity; outlawed in regard to business HISTORY BACKGROUND BRCA1 & BRCA2 - tumor suppresor genes that encode a protein. Mutations allow uncontrolled duplication. Women with mutation have 60% increase in breast cancer risk and 25-55% incrrease for ovarian cancer. SIMILARITY TO DRUG PATENTING tumor suppressor gene - a gene that
prevents uncontrolled cell division
Full transcript